Genentech, Inc.
Genentech, Inc. lists 81 drug products in the FDA National Drug Code directory.
Products
| NDC | Product | Strength | Type |
|---|---|---|---|
| 50242-135 | Actemra Injection, Solution, Concentrate | Tocilizumab 80 mg/4mL | Rx |
| 50242-136 | Actemra Injection, Solution, Concentrate | Tocilizumab 200 mg/10mL | Rx |
| 50242-138 | Actemra Injection, Solution | Tocilizumab 162 mg/.9mL | Rx |
| 50242-137 | Actemra Injection, Solution, Concentrate | Tocilizumab 400 mg/20mL | Rx |
| 50242-143 | Actemra ACTPen Injection, Solution | Tocilizumab 162 mg/.9mL | Rx |
| 50242-085 | Activase Kit | Rx | |
| 50242-044 | Activase Kit | Rx | |
| 50242-130 | Alecensa Capsule | Alectinib Hydrochloride 150 mg/1 | Rx |
| 50242-060 | Avastin Injection, Solution | Bevacizumab 100 mg/4mL | Rx |
| 50242-061 | Avastin Injection, Solution | Bevacizumab 400 mg/16mL | Rx |
| 50242-041 | Cathflo Activase Injection, Powder, Lyophilized, For Solution | Alteplase 2.2 mg/2mL | Rx |
| 0004-0298 | CellCept Injection, Powder, Lyophilized, For Solution | Mycophenolate Mofetil Hydrochloride 500 mg/20mL | Rx |
| 0004-0261 | CellCept Powder, For Suspension | Mycophenolate Mofetil 200 mg/mL | Rx |
| 0004-0260 | CellCept Tablet, Film Coated | Mycophenolate Mofetil 500 mg/1 | Rx |
| 0004-0259 | CellCept Capsule | Mycophenolate Mofetil 250 mg/1 | Rx |
| 50242-125 | Columvi Solution, Concentrate | Glofitamab 2.5 mg/2.5mL | Rx |
| 50242-127 | Columvi Concentrate | Glofitamab 10 mg/10mL | Rx |
| 50242-717 | Cotellic Tablet, Film Coated | Cobimetinib Fumarate 20 mg/1 | Rx |
| 50242-007 | Enspryng Injection, Solution | Satralizumab 120 mg/mL | Rx |
| 50242-140 | Erivedge Capsule | Vismodegib 150 mg/1 | Rx |
| 50242-123 | Esbriet Tablet, Coated | Pirfenidone 801 mg/1 | Rx |
| 50242-122 | Esbriet Tablet, Coated | Pirfenidone 267 mg/1 | Rx |
| 50242-175 | Evrysdi Powder, For Solution | Risdiplam .75 mg/mL | Rx |
| 50242-202 | Evrysdi Tablet | Risdiplam 5 mg/1 | Rx |
| 50242-210 | Gavreto Capsule | Pralsetinib 100 mg/1 | Rx |
| 50242-070 | Gazyva Injection, Solution, Concentrate | Obinutuzumab 1000 mg/40mL | Rx |
| 50242-930 | Hemlibra Injection, Solution | Emicizumab 300 mg/2mL | Rx |
| 50242-920 | Hemlibra Injection, Solution | Emicizumab 30 mg/mL | Rx |
| 50242-921 | Hemlibra Injection, Solution | Emicizumab 60 mg/.4mL | Rx |
| 50242-927 | Hemlibra Injection, Solution | Emicizumab 12 mg/.4mL | Rx |
| 50242-922 | Hemlibra Injection, Solution | Emicizumab 105 mg/.7mL | Rx |
| 50242-923 | Hemlibra Injection, Solution | Emicizumab 150 mg/mL | Rx |
| 50242-132 | Herceptin Injection, Powder, Lyophilized, For Solution | Trastuzumab 150 mg/7.4mL | Rx |
| 50242-077 | Herceptin Hylecta Injection, Solution | Trastuzumab 600 mg/5mL; Hyaluronidase (human Recombinant) 10000 U/5mL | Rx |
| 50242-079 | Itovebi Tablet, Film Coated | Inavolisib 9 mg/1 | Rx |
| 50242-084 | Itovebi Tablet, Film Coated | Inavolisib 3 mg/1 | Rx |
| 50242-088 | Kadcyla Injection, Powder, Lyophilized, For Solution | Trastuzumab Emtansine 20 mg/mL | Rx |
| 50242-087 | Kadcyla Injection, Powder, Lyophilized, For Solution | Trastuzumab Emtansine 20 mg/mL | Rx |
| 50242-082 | Lucentis Injection, Solution | Ranibizumab 6 mg/mL | Rx |
| 50242-080 | Lucentis Injection, Solution | Ranibizumab 10 mg/mL | Rx |
| 50242-142 | Lunsumio Concentrate | Mosunetuzumab 30 mg/30mL | Rx |
| 50242-159 | Lunsumio Concentrate | Mosunetuzumab 1 mg/mL | Rx |
| 50242-201 | Lunsumio Velo Injection | Mosunetuzumab 45 mg/mL | Rx |
| 50242-177 | Lunsumio Velo Injection | Mosunetuzumab 5 mg/.5mL | Rx |
| 50242-150 | Ocrevus Injection | Ocrelizumab 300 mg/10mL | Rx |
| 50242-554 | Ocrevus Zunovo Injection, Solution | Ocrelizumab 920 mg/23mL; Hyaluronidase (human Recombinant) 23000 U/23mL | Rx |
| 50242-145 | Perjeta Injection, Solution, Concentrate | Pertuzumab 30 mg/mL | Rx |
| 50242-245 | Phesgo Injection, Solution | Pertuzumab 1200 mg/15mL; Trastuzumab 600 mg/15mL; Hyaluronidase (human Recombinant) 30000… | Rx |
| 50242-260 | Phesgo Injection, Solution | Pertuzumab 600 mg/10mL; Trastuzumab 600 mg/10mL; Hyaluronidase (human Recombinant) 20000… | Rx |
| 50242-115 | Piasky Injection, Solution | Crovalimab 340 mg/2mL | Rx |
| 50242-105 | Polivy Injection, Powder, Lyophilized, For Solution | Polatuzumab Vedotin 140 mg/7.52mL | Rx |
| 50242-103 | Polivy Injection, Powder, Lyophilized, For Solution | Polatuzumab Vedotin 30 mg/1.88mL | Rx |
| 50242-100 | Pulmozyme Solution | Dornase Alfa 1 mg/mL | Rx |
| 50242-053 | Rituxan Injection, Solution | Rituximab 10 mg/mL | Rx |
| 50242-051 | Rituxan Injection, Solution | Rituximab 10 mg/mL | Rx |
| 50242-109 | Rituxan Hycela Injection, Solution | Rituximab 120 mg/mL; Hyaluronidase (human Recombinant) 2000 U/mL | Rx |
| 50242-108 | Rituxan Hycela Injection, Solution | Rituximab 120 mg/mL; Hyaluronidase (human Recombinant) 2000 U/mL | Rx |
| 50242-623 | Rozlytrek Pellet | Entrectinib 50 mg/201 | Rx |
| 50242-094 | Rozlytrek Capsule | Entrectinib 200 mg/1 | Rx |
| 50242-091 | Rozlytrek Capsule | Entrectinib 100 mg/1 | Rx |
| 50242-078 | Susvimo Injection, Solution | Ranibizumab 100 mg/mL | Rx |
| 0004-0800 | Tamiflu Capsule | Oseltamivir Phosphate 75 mg/1 | Rx |
| 0004-0822 | Tamiflu Powder, For Suspension | Oseltamivir Phosphate 6 mg/mL | Rx |
| 0004-0802 | Tamiflu Capsule | Oseltamivir Phosphate 30 mg/1 | Rx |
| 50242-918 | Tecentriq Injection, Solution | Atezolizumab 840 mg/14mL | Rx |
| 50242-917 | Tecentriq Injection, Solution | Atezolizumab 1200 mg/20mL | Rx |
| 50242-933 | Tecentriq Hybreza Injection | Atezolizumab 1875 mg/15mL; Hyaluronidase (human Recombinant) 30000 U/15mL | Rx |
| 50242-120 | TNKase Kit | Rx | |
| 50242-014 | TNKase Kit | Rx | |
| 50242-176 | TNKase Kit | Rx | |
| 50242-096 | Vabysmo Injection, Solution | Faricimab 6 mg/.05mL | Rx |
| 50242-877 | Xofluza Tablet, Film Coated | Baloxavir Marboxil 80 mg/1 | Rx |
| 50242-860 | Xofluza Tablet, Film Coated | Baloxavir Marboxil 40 mg/1 | Rx |
| 50242-617 | Xofluza Granule, For Suspension | Baloxavir Marboxil 40 mg/1 | Rx |
| 50242-599 | Xofluza Granule, For Suspension | Baloxavir Marboxil 30 mg/1 | Rx |
| 50242-583 | Xofluza Granule, For Solution | Baloxavir Marboxil 40 mg/20mL | Rx |
| 50242-227 | Xolair Injection, Solution | Omalizumab 300 mg/2mL | Rx |
| 50242-040 | Xolair Injection, Solution | Omalizumab 150 mg/1.2mL | Rx |
| 50242-214 | Xolair PFS Injection, Solution | Omalizumab 75 mg/.5mL | Rx |
| 50242-215 | Xolair PFS Injection, Solution | Omalizumab 150 mg/mL | Rx |
| 50242-090 | Zelboraf Tablet, Film Coated | Vemurafenib 240 mg/1 | Rx |
Recalls by Genentech, Inc.
- D-0509-2024 Jun 5, 2024 · Class II
Lack of Assurance of Sterility: Deformed stoppers observed during filling operations for Cathflo Activase. - D-0416-2018 Feb 21, 2018 · Class III
Labeling: Not Elsewhere Classified: Schedule IV controlled substance indicator of CIV being omitted from the product carton, primary label is correct. - D-1175-2017 Sep 27, 2017 · Class I
Non-Sterility:presence of cracked or chipped glass at the neck of Sterile Water for Injection vials. - D-097-2013 Dec 26, 2012 · Class III
Short Fill: some bottles contained less than 120-count per labeled claim.